Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin

Journal of General Virology

Volumn 92, Issue 10, 2011, Pages 2367-2373

  Huang, Xin ^a,b   Jin, Wei ^a,b   Griffin, George E ^c   Shattock, Robin J ^c   Hu, Qinxue ^a,c  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; CARBOHYDRATE BINDING PROTEIN; CYANOVIRIN N; GLYCOPROTEIN GP 120; GRIFFITHSIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; DEGLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE; VIRUS ISOLATION;

ALGAL PROTEINS; ANTIBODIES, NEUTRALIZING; ANTIVIRAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; GLYCOSYLATION; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; LECTINS; MANNOSE; MANNOSE-BINDING LECTINS; MUTAGENESIS, SITE-DIRECTED; PLANT LECTINS; PROTEIN BINDING;

GALANTHUS NIVALIS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052936296     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.033092-0     Document Type: Article

References (32)

1. Alexandre, K. B., Gray, E. S., Lambson, B. E., Moore, P. L., Choge, I. A., Mlisana, K., Karim, S. S., McMahon, J., O'Keefe, B. & other authors (2010). Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, cyanovirin- N and scytovirin. Virology 402, 187-196.
2. Balzarini, J. (2005). Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect Dis 5, 726-731.
3. Balzarini, J., Van Laethem, K., Peumans, W. J., Van Damme, E. J., Bolmstedt, A., Gago, F. & Schols, D. (2006). Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes. J Virol 80, 8411-8421.
4. Bewley, C. A. (2001). Solution structure of a cyanovirin-N:Man a1-2Mana complex: structural basis for high-affinity carbohydratemediated binding to gp120. Structure 9, 931-940.
5. Bolmstedt, A. J., O'Keefe, B. R., Shenoy, S. R., McMahon, J. B. & Boyd, M. R. (2001). Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide- specific manner. Mol Pharmacol 59, 949-954.
6. Boyd, M. R., Gustafson, K. R., McMahon, J. B., Shoemaker, R. H., O'Keefe, B. R., Mori, T., Gulakowski, R. J., Wu, L., Rivera, M. I. & other authors (1997). Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother 41, 1521-1530.
7. Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L. & other authors (2003). Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065-2071.
8. Emau, P., Tian, B., O'Keefe, B. R., Mori, T., McMahon, J. B., Palmer, K. E., Jiang, Y., Bekele, G. & Tsai, C. C. (2007). Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide. J Med Primatol 36, 244-253.
9. Esser, M. T., Mori, T., Mondor, I., Sattentau, Q. J., Dey, B., Berger, E. A., Boyd, M. R. & Lifson, J. D. (1999). Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J Virol 73, 4360-4371.
10. Gallaher, W. R., Ball, J. M., Garry, R. F., Martin-Amedee, A. M. & Montelaro, R. C. (1995). A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 11, 191-202.
11. Hu, Q. X., Barry, A. P., Wang, Z. X., Connolly, S. M., Peiper, S. C. & Greenberg, M. L. (2000). Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J Virol 74, 11858-11872.
12. Hu, Q., Frank, I., Williams, V., Santos, J. J., Watts, P., Griffin, G. E., Moore, J. P., Pope, M. & Shattock, R. J. (2004). Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 199, 1065-1075.
13. Hu, Q., Napier, K. B., Trent, J. O., Wang, Z., Taylor, S., Griffin, G. E., Peiper, S. C. & Shattock, R. J. (2005). Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. J Mol Biol 350, 699-712.
14. Hu, Q., Mahmood, N. & Shattock, R. J. (2007). High-mannosespecific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization. Virology 368, 145-154.
15. Huskens, D., Van Laethem, K., Vermeire, K., Balzarini, J. & Schols, D. (2007). Resistance of HIV-1 to the broadly HIV-1-neutralizing, anticarbohydrate antibody 2G12. Virology 360, 294-304.
16. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. & Hendrickson, W. A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
17. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N. & Gregory, T. J. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J BiolChem265, 10373-10382.
18. Mori, T., O'Keefe, B. R., Sowder, R. C., II, Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., Jr & other authors (2005). Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem 280, 9345-9353.
19. O'Keefe, B. R., Vojdani, F., Buffa, V., Shattock, R. J., Montefiori, D. C., Bakke, J., Mirsalis, J., d'Andrea, A. L., Hume, S. D. & other authors (2009). Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci U S A 106, 6099-6104.
20. Reitter, J. N., Means, R. E. & Desrosiers, R. C. (1998). A role for carbohydrates in immune evasion in AIDS. Nat Med 4, 679-684.
21. Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K.O., Kwong, P. D. & Moore, J. P. (2002). Themannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76, 7293-7305.
22. Scanlan, C. N., Pantophlet, R., Wormald, M. R., Ollmann Saphire, E., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M. & Burton, D. R. (2002). The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of a1-.2 mannose residues on the outer face of gp120. J Virol 76, 7306-7321.
23. Shattock, R. J. & Moore, J. P. (2003). Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1, 25-34.
24. Tsai, C. C., Emau, P., Jiang, Y., Tian, B., Morton, W. R., Gustafson, K. R. & Boyd, M. R. (2003). Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res Hum Retroviruses 19, 535-541.
25. Tsai, C. C., Emau, P., Jiang, Y., Agy, M. B., Shattock, R. J., Schmidt, A., Morton, W. R., Gustafson, K. R. & Boyd, M. R. (2004). Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Hum Retroviruses 20, 11-18.
26. Van Damme, E. J. M., Allen, A. K. & Peumans, W. J. (1987). Isolation and characterization of a lectin with exclusive specificity towards mannose from snowdrop (Galanthus nivalis) bulbs. FEBS Lett 215, 140-144.
27. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M. & other authors (2003). Antibody neutralization and escape by HIV-1. Nature 422, 307-312.
28. Witvrouw, M., Fikkert, V., Hantson, A., Pannecouque, C., O'Keefe, B. R., McMahon, J., Stamatatos, L., de Clercq, E. & Bolmstedt, A. (2005). Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J Virol 79, 7777-7784.
29. Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A. & Sodroski, J. G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.
30. Zhu, X., Borchers, C., Bienstock, R. J. & Tomer, K. B. (2000). Mass spectrometric characterization of the glycosylation pattern of HIVgp120 expressed in CHO cells. Biochemistry 39, 11194-11204.
31. Ziółkowska, N. E., O'Keefe, B. R., Mori, T., Zhu, C., Giomarelli, B., Vojdani, F., Palmer, K. E., McMahon, J. B. & Wlodawer, A. (2006). Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate binding. Structure 14, 1127-1135.
32. Ziółkowska, N. E., Shenoy, S. R., O'Keefe, B. R., McMahon, J. B., Palmer, K. E., Dwek, R. A., Wormald, M. R. & Wlodawer, A. (2007). Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Proteins 67, 661-670.